Low production in January, February led to shortage of Remdesivir, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

One of the key reasons behind the current shortfall in supply is the scaling down or stoppage of production of the drug in January and February due to the low Covid-19 caseload since December 2020 and the resultant low demand, pharma industry sources said., One of the key reasons behind the current shortfall in supply is the scaling down or stoppage of production of the drug in January and February due to the low Covid-19 caseload since December 2020 and the resultant low demand, pharma industry sources said., , Read More